In turn, AIDS is beginning to beget serious poverty, and the Panos Institute's latest report focuses on
this economic impact of the disease.
In particular, these handouts cover the following specific content about tuberculosis in South Africa: Case study of one communicable disease, such as malaria or tuberculosis, at a country scale, either an LIDC or EDC, including: o environmental and human causes of the disease o prevalence, incidence and patterns of the disease o socio -
economic impacts of the disease o direct and indirect strategies used by government and international agencies to mitigate against the disease and respond to outbreaks.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global
economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global
economic uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any adverse
impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse
impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the
impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over financial reporting; 29) the outcome or
impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
«Poverty and the many stresses that come with social disadvantage have long been linked to cardiovascular
disease, but how we live, work, and play has a great
impact on heart health for people from a broad range
of economic and cultural backgrounds,» explains David Siscovick, MD, MPH, Senior Vice President for Research at The New York Academy
of Medicine and Chair
of the American Heart Association's (AHA) Council on Epidemiology and Prevention.
«An effective vaccine against uterine
diseases will have a significant positive
impact on the dairy industry, limiting the use
of antibiotics, and decreasing
economic losses due to these disorders.
These findings may help policy - makers and
economic forecasters adjust their predictions for the total
impact of Alzheimer's
disease and other conditions.
NIH research fuels the pipeline
of discovery and innovation necessary to prevent, treat and cure our most vexing
diseases and it has a significant
economic impact, supporting more than 350,000 jobs across the United States and contributing some $ 60 billion annually in
economic activity....
A modification
of the method for priorization proposed by the OIE (World Organisation for Animal Health) was used to produce a final list
of 15 pathogens and a clear separation was adopted between human health and
economic component
of the
impact of the
diseases.
Ultimately frequent and accurate information about
diseases outbreaks improves horse welfare and helps to prevent negative
economic impact that can result from decreased horse use due to a fear
of spreading infection.
Disease, desolation
of species, environmental
impact, racism, cultural - ism,
economic and political issues etc..
(1) to provide new and additional assistance from the United States to the most vulnerable developing countries, including the most vulnerable communities and populations therein, in order to support the development and implementation
of climate change adaptation programs and activities that reduce the vulnerability and increase the resilience
of communities to climate change
impacts, including
impacts on water availability, agricultural productivity, flood risk, coastal resources, timing
of seasons, biodiversity,
economic livelihoods, health and
diseases, and human migration; and
He discussed the escalating scale
of impacts we could expect from unchecked climate change: from deaths and injuries from heat, to pollution, food - related illnesses, altered vectors for
diseases such as malaria, crop failure and water shortages, mass migration, resource wars,
economic collapse, and ecosystem collapse with mass extinctions.
These types
of urban agriculture have a more pronounced
economic impact and higher profitability, but their externalities for the city and urban populations, especially those
of the intensive larger scale enterprises, tend to be higher especially through risk
of water and soil contamination due to intensive use
of agro chemicals, health risks from use
of contaminated water for irrigation and risks
of animal - human
disease transfers (zoonosis).
Current models
of climate change include sea level rise, land degradation, regional changes in temperature and precipitation patterns, and some consequences for agriculture, but without modeling the feedbacks that these significant
impacts would have on the Human System, such as geographic and
economic displacement, forced migration, destruction
of infrastructure, increased
economic inequality, nutritional sustenance, fertility, mortality, conflicts, and spread
of diseases or other human health consequences [135,136].
Abbott Labs, Amman • Jordan 2008 — 2009 Professional Sales Representative Instrumental in increasing health care, public and patient awareness about Psoriasis as a systemic chronic
disease, its
impact on social and
economic life
of the patients and the doctor's awareness about the available treatments for chronic
disease starting from the early treatment with topical to the newest agents which included the systemic biologics (TNF alpha blockers).
In addition, child maltreatment has been shown to have lifelong adverse health, social, and
economic consequences for survivors, including behavioural problems; increased risk
of delinquency, criminality and violent behaviour; increased risk
of chronic
diseases; lasting
impacts or disability from physical injury; reduced health - related quality
of life; and lower levels
of economic well - being.